At a glance
- Originator Servier
- Class Anti-inflammatories; Dipeptides
- Mechanism of Action Neurokinin 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Chronic obstructive pulmonary disease
Most Recent Events
- 03 Nov 2003 No development reported - Preclinical for Chronic obstructive pulmonary disease in France (unspecified route)
- 09 Jul 1997 New profile
- 09 Jul 1997 Preclinical development for Chronic obstructive pulmonary disease in France (Unknown route)